HOME >> BIOLOGY >> NEWS
Glowing bacteria show researchers how an anti-flu-virus drug may prevent bacterial pneumonia

(Memphis, Tenn.--March 7, 2003) Investigators at St. Jude Children's Research Hospital have shown in mice how the potentially deadly cooperation between influenza virus and bacterial pneumonia infections can be foiled, even if treatment is delayed and flu virus levels in the lung have peaked.

The St. Jude team showed that the flu virus enzyme neuraminidase (NA) strips lung cells of their protective forest of molecules called sialic acid. The unprotected cells are then vulnerable to subsequent infection with Streptococcus pneumoniae bacteria. But treatment of the mice with the NA-inhibitor drug ostelamivir blocked the activity of flu virus NA and offered significant protection against pneumonia. The study's findings appear in the March 15 issue of the Journal of Infectious Diseases.

"We previously showed that when Streptococcus pneumoniae was given to mice seven days after they had been infected with flu virus, the mortality was extremely high," said Jonathan McCullers, MD, the lead author of the report. "Our current study using tissue in lab dishes, as well as live mice, showed that viral NA is the key to this deadly synergy between flu virus and pneumonia bacteria. The streptococcus bacteria also have NA," McCullers said, "but it is much less efficient than the viral enzyme in cutting away at the lung cell's sialic acid barrier."

The St. Jude finding is important because a combined infection with influenza and pneumonia is the sixth leading cause of all deaths worldwide, and is the top cause of death due to an infection, according to McCullers assistant member in the Department of Infectious Diseases at St. Jude. Moreover, the overall death rate associated with pneumonia and influenza increased by 59% between 1979 and 1994, according to a 1996 report in the Journal of the American Medical Association.

"The flu virus targets the sialic acid molecules on the lung cell membrane surface so it can get inside the lung cell and reproduce
'"/>

Contact: Bonnie Cameron
bonnie.cameron@stjude.org
901-495-4815
St. Jude Children's Research Hospital
7-Mar-2003


Page: 1 2 3

Related biology news :

1. Glowing microspheres improve fluorescence measurements
2. Glowing technique could detect river pollution
3. Glowing Bacteria: DuPont And UD Scientists Detect Poultry Toxin And Other Environmental Contaminants
4. Glowing Cyanobacteria Gives Researchers New Clues To Circadian Rhythms
5. Researchers find color sensitive atomic switch in bacteria
6. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
7. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
8. Scientists discover potential new way to control drug-resistant bacteria
9. 22nd amino acid synthesized and added to genetic code of e. coli bacteria
10. Missing genes may help explain why plague bacteria are so deadly
11. Complex cells likely arose from combination of bacterial and extreme-microbe genomes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/26/2019)... ... July 25, 2019 , ... ... first mixed reality headsets to include a new generation eye tracker with hassle-free ... in Los Angeles, California (July 30 - August 1). SIGGRAPH attendees will be ...
(Date:7/23/2019)... ... July 23, 2019 , ... ... easy-to-understand, web-based genetic counseling, today announced that the company has expanded its database ... polyposis (MAP), familial hypercholesterolemia (FH), and Parkinson’s disease. , The expanded content comes ...
(Date:7/23/2019)... ... July 23, 2019 , ... ... 100% bioactive glass synthetic biologic strip indicated for spine and orthopedic use. Bioactive ... human bone. Bioactive glass has been clinically-proven in orthopedics for over 30 years ...
Breaking Biology News(10 mins):
(Date:7/9/2019)... ... July 08, 2019 , ... Balluff ... Indicator was recognized as the 2019 Innovative Product of the Year which highlights ... awards were during Sensors Expo & Conference 2019, held this week ...
(Date:6/18/2019)... YORK and SOMERSET, N.J. (PRWEB) , ... June ... ... Catalent Biologics, today announced that they have entered into an agreement for production ... product candidates, IC-100 for the treatment of rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) ...
(Date:6/11/2019)... ... June 10, 2019 , ... Thought Technology Ltd is pleased ... Biofeedback Tech Ltd as its authorised distributor for the UK and ... therapeutic treatments and clinical assessment protocols to treat stress related disorders as well ...
(Date:6/11/2019)... ... June 11, 2019 , ... ... Carilion Clinic, a national leader in opioid treatment, announced today they are partnering ... , Mytonomy recently deployed its virtual care platform at the Mayo Clinic ...
Breaking Biology Technology:
Cached News: